Curidium Discovers Significantly Different Patient Subgroups in …
PR Inside - Curidium Medica plc, (LSE: CUR) today announced that it has discovered four unique and statistically significantly different subgroups of schizophrenia/bipolar disorder patients based on their gene expression profiles. Using its proprietary …